Entrar/Registro  
HOME SPANISH
 
Dermatología Revista Mexicana
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Dermatología Revista Mexicana >Year 2014, Issue 1


Moreno VK, Ponce ORM, Ubbelohde HT
Chanroid (Ducrey Disease)
Dermatología Rev Mex 2014; 58 (1)

Language: Español
References: 28
Page: 33-39
PDF: 638.92 Kb.


Full text




ABSTRACT

Sexually transmitted diseases are clinical syndromes caused by diverse pathogens. This paper reviews chancroid, a genital and anogenital ulcerative STD. There have been estimates of an incidence of 6 to 7 million cases worldwide, though these numbers have been declining since 1995. Chancroid has generated a renewed interest because of its capacity to amplify the transmission of HIV. At 160 years from its original description there are new diagnostic methods, prevention and treatment that warrant constant update.


Key words: Haemophilus ducreyi, chanroid, soft chancre, Ducrey disease, genital ulcer, sexually transmitted disease.


REFERENCIAS

  1. Apers L, Crucitti T, Verbrugge R, Vandenbruaene M. Sexually transmitted infections: What’s new? Acta Clin Belg 2012;67:154-159.

  2. Shim BS. Current concepts in bacterial sexually transmitted diseases. Korean J Urol 2011;52:589-597.

  3. Mabey D. Epidemiology of STIs: worldwide. Am J Med 2010;38:216-219.

  4. Hammond GW. A history of the detection of Haemophilus ducreyi, 1889-1979. Sex Transm Dis 1996;23:93-96.

  5. Morse S. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev 1989;2:137-157.

  6. Albritton WL. Biology of Haemophilus ducreyi. Microbiol Rev 1989;53:377-389.

  7. Mohammed TT, Olumide YM. Chancroid and human immunodeficiency virus infection-a review. Int J Dermatol 2008;47:1-8.

  8. Steen R, Shrestha P. Can treatable sexually transmitted infections be eliminated from South-East Asia Region? Commun Dis News 2008;5:1-2.

  9. Spinola, SM. Chancroid and Haemophilus ducreyi. In: Holmes KK, Sparling PF, Stamm, WE, et al, eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill 2008:689-700.

  10. Spinola SM, Wild LM, Apicella MA, Gaspari AA, et al. Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994;169:1146-1150.

  11. Weiss HA, Thomas SL, Munabi Sk, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 2006;82:101-110.

  12. Li W, Katz BP, Spinola SM. Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages. Infect Immun 2012;80:4426-4434.

  13. Vakevainen M, Greenberg S, Hansen EJ. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect Immun 2003;71:5994- 6003.

  14. Elkins C, Morrow Kj, Olsen B. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA. Infect Immun 2000;68:1608-1619.

  15. Bauer ME, Townsend CA, Doster RS, Fortney KR, et al. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans. J Infect Dis 2009;199:684-692.

  16. Mount KLB, Townsend CA, Bauer ME. Haemophilus ducreyi is resistant to human antimicrobial peptides. Antimicrob Agent Chemother 2007;51:3391-3393.

  17. Bauer ME, Fortney KR, Harrison A, Janowicz DM, et al. Identification of Haemophilus ducreyi genes expressed during human infection. Mycrobiology 2008;154:1152- 1160.

  18. Calderon Jaimes E. Diagnóstico, tratamiento y prevención de las infecciones de transmisión sexual. Rev Fac Med UNAM 2002;45:110-117.

  19. Inamadar AC, Palit A. Chancroid: an update. Indian J Dermatol Venereol Leprol 2002;68:5-9.

  20. King R, Choudhri SN, Nasio J, et al. Clinical and in-situ cellular responses to Haemophilus ducreyi in the presence or absence of VIH infection. Int J STD 1998;9:531-536.

  21. Brown TJ, Yenmoore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999;41:511-532.

  22. Jones CC, Rosen T. Cultural diagnosis of chancroid. Arch Dermatol 1991;127:1823-1827.

  23. Kemp M, Christensen JJ, Lautenschlager S, Vall-Mayans M, et al . European guideline for the management of chanroid 2011. Int J STD AIDS 2011;22:241-244.

  24. Al-Tawfiq JA, Palmer KL, Chen CY, Haley JC, et al. Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge. J Infect Dis 1999;79:1283-1287.

  25. ALFA M. The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med Microbiol 2005;16:31-34.

  26. Workowki KA, Beman S, Centers for Disease Control and Prevention (CDC) sexually transmitted diseases treatment guidelines 2010. MMWR Recomm Rep 2010;59:1-110.

  27. Roett MA, Mayor MT, Uduhiri KA. Diagnosis and management of genital ulcers. Am Fam Physician 2012;85:254- 262.

  28. Nawrocki EM, Bedell HW, Humphreys TL. Resveratrol is cidal to both classes of Haemophilus ducreyi. Int J Antimcrob Agents 2013;41:477-479.






>Journals >Dermatología Revista Mexicana >Year 2014, Issue 1
 

· Journal Index 
· Links 






       
Copyright 2019